Sale of Securities

NewAmsterdam Pharma Co N.V. Filed 2025-08-27 Acc 0002004379-25-000002

Documents 1

2025-09-03 144 Sale of Securities
2025-09-02 8-K Regulation FD disclosure
2025-08-27 144 Sale of Securities
2025-08-27 4 Chief Accounting Officer sold 8,269 shares at $24.86 ($205,567)
2025-08-25 144 Sale of Securities
2025-08-25 4 Chief Scientific Officer sold 100,000 shares at an average $24.72 ($2,471,640)
2025-08-20 SCHEDULE 13D/A Beneficial Ownership Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…